Evaxion Biotech AS (EVAX) — Defensive Interval Ratio
Evaxion Biotech AS (EVAX) has a Defensive Interval Ratio of 216 days as of June 2026. Defensive assets of $1.86 Million (cash $-, short-term investments $-, receivables $1.86 Million) cover 216 days of daily cash needs of $8.58K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Evaxion Biotech AS Defensive Interval Ratio (2017–2025)
This chart shows how Evaxion Biotech AS's Defensive Interval Ratio has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the ratio stands at 216 days, meaning defensive assets of $1.86 Million can fund 216 days of operations without new revenue. For the complete balance sheet picture, see Evaxion Biotech AS assets under control.
Annual Defensive Interval Ratio for Evaxion Biotech AS (2017–2025)
The table below presents the year-by-year Defensive Interval Ratio for Evaxion Biotech AS from 2017 to 2025, covering 9 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See Evaxion Biotech AS (EVAX) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 90 days | $1.05 Million | $11.66K/day | $- | $- | ▼ -65 days |
| 2024 | 155 days | $1.86 Million | $11.97K/day | $- | $- | ▲ +100 days |
| 2023 | 55 days | $1.08 Million | $19.41K/day | $- | $165.00 | ▼ -71 days |
| 2022 | 127 days | $1.31 Million | $10.31K/day | $- | $- | ▼ -34 days |
| 2021 | 161 days | $1.90 Million | $11.84K/day | $- | $- | ▲ +28 days |
| 2020 | 133 days | $1.79 Million | $13.50K/day | $- | $- | ▼ -64 days |
| 2019 | 197 days | $931.00K | $4.72K/day | $- | $- | ▲ +167 days |
| 2018 | 30 days | $772.00K | $25.81K/day | $- | $- | ▼ -2544 days |
| 2017 | 2574 days | $2.14 Million | $830.14/day | $- | $- | — |